US giant Bioventus is acquiring Israel’s CartiHeal (see here previously) for $500 million. The decision came after a pivotal clinical trial of CartiHeal’s Agili-C knee cartilage implant.
https://www.calcalistech.com/ctech/articles/0,7340,L-3916642,00.html